COGSTATE LIMITED (CGS)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
CGS - COGSTATE LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.08
Index: ALL-ORDS
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.08
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$1.28
22 Apr |
OPEN $1.30 |
HIGH $1.30 |
37,122 LOW $1.28 |
-0.020| OTHER COMPANIES IN THE SAME SECTOR | |||
| 4DX . AT1 . BRN . CAT . CBL . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | 3.1 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 60.1 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 32.7 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 1.8 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 8.82 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 10.15 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 10.06 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | 6.38 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | 10.15 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 6.37 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 1.6 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 43 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 5.05 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 3.3 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 5.46 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 48 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 9 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | - |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
CGS STOCK CHART
FNArena News on CGS
| 1 |
Australian Broker Call *Extra* Edition – Oct 31, 2023Oct 31 2023 - Daily Market Reports |
| 2 |
FNArena Corporate Results Monitor – 24-08-2023Aug 24 2023 - Australia |
| 3 |
Australian Broker Call *Extra* Edition – May 16, 2023May 16 2023 - Daily Market Reports |
| 4 |
Weekly Ratings, Targets, Forecast Changes – 12-05-23May 15 2023 - Weekly Reports |
| 5 |
Australian Broker Call *Extra* Edition – May 12, 2023May 12 2023 - Daily Market Reports |
Latest Medical Equipment & Devices News
| 1 |
Dr Boreham’s Crucible: 4D Medical10:00 AM - Small Caps |
| 2 |
Uptrend Resumed For ResMedMar 19 2024 - Technicals |
| 3 |
Dr Boreham’s Crucible: CochlearFeb 28 2024 - Australia |
| 4 |
Rudi Interviewed: Ongoing Potential In Technology & GrowthFeb 19 2024 - Rudi's View |
| 5 |
Dr Boreham’s Crucible: ArtryaFeb 15 2024 - Small Caps |
| 6 |
ResMed Recovery Turns Into Hollywood ScriptJan 31 2024 - Australia |
| 7 |
ResMed Makes A ComebackJan 29 2024 - Australia |
| 8 |
ResMed: The Recovery Has BegunJan 23 2024 - Technicals |
| 9 |
Dr Boreham’s Crucible: Pro MedicusOct 23 2023 - Australia |
| 10 |
Dr Boreham’s Crucible: CyclopharmOct 09 2023 - Small Caps |